RS58881B1 - Dugodelujući superagonisti glikoproteinskih hormona - Google Patents

Dugodelujući superagonisti glikoproteinskih hormona

Info

Publication number
RS58881B1
RS58881B1 RS20190625A RSP20190625A RS58881B1 RS 58881 B1 RS58881 B1 RS 58881B1 RS 20190625 A RS20190625 A RS 20190625A RS P20190625 A RSP20190625 A RS P20190625A RS 58881 B1 RS58881 B1 RS 58881B1
Authority
RS
Serbia
Prior art keywords
glycoprotein hormone
superagonists
acting
long
hormone long
Prior art date
Application number
RS20190625A
Other languages
English (en)
Inventor
Mariusz Szkudlinski
Bruce D Weintraub
Original Assignee
Trophogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophogen Inc filed Critical Trophogen Inc
Publication of RS58881B1 publication Critical patent/RS58881B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RS20190625A 2012-07-30 2013-07-29 Dugodelujući superagonisti glikoproteinskih hormona RS58881B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261677331P 2012-07-30 2012-07-30
EP13826476.7A EP2880164B1 (en) 2012-07-30 2013-07-29 Glycoprotein hormone long-acting superagonists
PCT/US2013/052510 WO2014022283A2 (en) 2012-07-30 2013-07-29 Glycoprotein hormone long-acting superagonists

Publications (1)

Publication Number Publication Date
RS58881B1 true RS58881B1 (sr) 2019-08-30

Family

ID=49995487

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190625A RS58881B1 (sr) 2012-07-30 2013-07-29 Dugodelujući superagonisti glikoproteinskih hormona

Country Status (21)

Country Link
US (5) US9187545B2 (sr)
EP (4) EP2880164B1 (sr)
JP (1) JP6429774B2 (sr)
CN (3) CN112458096A (sr)
AR (1) AR091936A1 (sr)
AU (2) AU2013296709B2 (sr)
BR (1) BR112015001885B1 (sr)
CA (2) CA2880520C (sr)
DK (2) DK2880164T3 (sr)
ES (2) ES2727659T3 (sr)
HR (1) HRP20190847T1 (sr)
HU (1) HUE044016T2 (sr)
MX (1) MX360717B (sr)
NZ (1) NZ707016A (sr)
PL (2) PL2880164T3 (sr)
PT (2) PT3572515T (sr)
RS (1) RS58881B1 (sr)
RU (2) RU2018132561A (sr)
UA (1) UA118653C2 (sr)
WO (1) WO2014022283A2 (sr)
ZA (1) ZA201502778B (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
PT3572515T (pt) 2012-07-30 2021-10-22 Trophogen Inc Superagonistas de ação prolongada de hormonas glicoproteicas
AU2014346859B2 (en) 2013-11-05 2019-06-20 Trophogen Inc. Glycoprotein hormone long-acting superagonists
BR102015032660B1 (pt) 2015-12-28 2019-05-28 Ouro Fino Saúde Animal Participações S.A. PROCESSO DE PRODUÇÃO DE UMA GONADOTROFINA CORIÔNICA EQUINA RECOMBINANTE (reCG): COMPOSIÇÃO VETERINÁRIA E USO

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
ATE65407T1 (de) 1984-04-03 1991-08-15 Serono Lab Verfahren zur herbeifuehrung der ovulation.
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
DE3751602T2 (de) 1987-05-12 1996-05-02 Serono Pharm Praep Subkutane Verabreichung des humanen Choriongonadotropins.
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US6018026A (en) 1988-01-22 2000-01-25 Zymogenetics, Inc. Biologically active dimerized and multimerized polypeptide fusions
WO1990002812A1 (en) 1988-09-01 1990-03-22 Applied Research Systems Ars Holding N.V. Methods for producing gonadotropin and tsh super-agonists
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US6225449B1 (en) 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
EP0404458A3 (en) 1989-06-19 1992-03-04 Bunge (Australia) Proprietary Limited Ovine follicle stimulating hormone
EP0531407B1 (en) 1990-05-08 2000-02-09 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
ATE138803T1 (de) 1990-07-31 1996-06-15 Liposome Co Inc Anhäufung von aminosäuren und peptiden in liposomen
US5612034A (en) 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
CA2131630A1 (en) 1992-03-10 1993-09-30 Yury E. Khudyakov Exchangeable template reaction
US5604198A (en) 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
RU2213099C2 (ru) * 1994-08-12 2003-09-27 Вашингтон Юниверсити Одноцепочечный белок, модулятор гормонов лютеинизирующего, фолликулостимулирующего, тиреостимулирующего и хорионического гонадотропина (варианты), молекула нуклеиновой кислоты (варианты), вектор (варианты), линия трансформированных клеток сно (варианты), способ продуцирования одноцепочечного белка (варианты)
US7005505B1 (en) 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6361992B1 (en) 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists
EP1947117B1 (en) 1996-05-08 2013-07-17 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Glycoprotein hormone superagonists
DK0956339T3 (da) 1996-08-23 2006-01-30 Licentia Oy Rekombinant vaskulær endotelcellevækstfaktor D (VEGF-D)
EP0941310A1 (en) 1996-10-11 1999-09-15 THE TEXAS A&M UNIVERSITY SYSTEM Methods for the generation of primordial germ cells and transgenic animal species
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US6485942B1 (en) 1997-02-14 2002-11-26 Genentech, Inc. Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
US6080912A (en) 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
DK1775346T3 (da) * 1997-06-25 2009-09-28 Merck Serono Sa Disulfid-tværbundne glycoproteinhormonanaloger, deres fremstilling og anvendelse
US6281408B1 (en) 1998-02-20 2001-08-28 Thomas Jefferson University Efficient method for production of compound transgenic animals
EP1115866A1 (en) 1998-09-22 2001-07-18 University of Maryland at Baltimore Cystine knot growth factor mutants
WO2000025805A1 (en) 1998-11-02 2000-05-11 Ludwig Institute For Cancer Research Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
JP2002541213A (ja) * 1999-04-13 2002-12-03 インヘール セラピューティック システムズ， インコーポレイテッド 不妊症の処置のための乾燥粉末処方物の肺投与
AU5023300A (en) 1999-05-20 2000-12-12 Scios Inc. Vascular endothelial growth factor variants
US6555660B2 (en) 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US20020127652A1 (en) 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
AU2002317333C1 (en) 2001-08-01 2009-06-25 University Of Bristol VEGF isoform
EP1687333A2 (en) 2003-10-30 2006-08-09 Pharmexa A/S Method for down-regulation of vegf
AU2004287645A1 (en) * 2003-11-06 2005-05-19 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
WO2005072417A2 (en) 2004-01-27 2005-08-11 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
KR20070026463A (ko) * 2004-03-19 2007-03-08 트로포젠 인코포레이티드 여포자극호로몬 초작동제
EP1738174A2 (en) 2004-03-31 2007-01-03 Trophogen, Inc. Human glycoprotein hormone superagonists and uses thereof
CN101067118A (zh) * 2007-04-24 2007-11-07 新疆农业科学院微生物应用研究所 一种重组牛促卵泡激素在毕赤酵母中的表达
WO2011075606A2 (en) * 2009-12-18 2011-06-23 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
PT3572515T (pt) 2012-07-30 2021-10-22 Trophogen Inc Superagonistas de ação prolongada de hormonas glicoproteicas
US9905908B2 (en) 2014-01-14 2018-02-27 Luxshare Precision Industry Co., Ltd. Antenna structure with proximity sensor

Also Published As

Publication number Publication date
ES2727659T3 (es) 2019-10-17
RU2015103059A (ru) 2016-09-27
CA3108181A1 (en) 2014-02-06
UA118653C2 (uk) 2019-02-25
ZA201502778B (en) 2021-09-29
DK3572515T3 (da) 2021-10-11
BR112015001885B1 (pt) 2022-08-09
US20140371146A1 (en) 2014-12-18
CN104619846B (zh) 2020-11-03
US20230357345A1 (en) 2023-11-09
AU2013296709A1 (en) 2015-02-19
PL2880164T3 (pl) 2019-10-31
MX2015001414A (es) 2015-09-23
JP2015524819A (ja) 2015-08-27
PL3572515T3 (pl) 2022-04-11
DK2880164T3 (da) 2019-05-20
CN104619846A (zh) 2015-05-13
AU2018203815B2 (en) 2019-12-12
PT3572515T (pt) 2021-10-22
RU2668174C2 (ru) 2018-09-26
US10766941B2 (en) 2020-09-08
US9187545B2 (en) 2015-11-17
WO2014022283A2 (en) 2014-02-06
HUE044016T2 (hu) 2019-09-30
PT2880164T (pt) 2019-06-05
CA2880520C (en) 2021-02-09
US20140031530A1 (en) 2014-01-30
NZ707016A (en) 2017-08-25
RU2018132561A (ru) 2018-11-02
CN112409472A (zh) 2021-02-26
EP2880164A4 (en) 2016-03-09
JP6429774B2 (ja) 2018-11-28
EP3572515B1 (en) 2021-07-21
AU2018203815A1 (en) 2018-06-21
ES2894135T3 (es) 2022-02-11
CA2880520A1 (en) 2014-02-06
EP3572515A1 (en) 2019-11-27
HRP20190847T1 (hr) 2019-09-06
US20210054041A1 (en) 2021-02-25
US20160075751A1 (en) 2016-03-17
EP4012033A1 (en) 2022-06-15
EP2880164A2 (en) 2015-06-10
WO2014022283A3 (en) 2014-04-03
MX360717B (es) 2018-11-13
AR091936A1 (es) 2015-03-11
EP3533874A1 (en) 2019-09-04
US9249205B2 (en) 2016-02-02
BR112015001885A2 (pt) 2017-11-07
AU2013296709B2 (en) 2018-03-08
EP2880164B1 (en) 2019-04-24
CN112458096A (zh) 2021-03-09

Similar Documents

Publication Publication Date Title
ZA201702364B (en) Glucagon analogues
HK1206757A1 (en) Glucagon analogues
IL236120A0 (en) Peptide analogs of exendin–4
EP2900264A4 (en) GLYKOPROTEINZUBEREITUNGEN
EP2857033A4 (en) SKIN-PUNKING PEPTIDE
EP2812347A4 (en) AUTOPHAGIA-INDUCING PEPTIDE
PT2938353T (pt) Péptidos anti-inflamatórios
HK1209138A1 (en) Peptides
ZA201502778B (en) Glycoprotein hormone long-acting superagonists
EP2865686A4 (en) EGFR-BINDING PEPTIDE
GB201200555D0 (en) Peptide
GB201204868D0 (en) Peptides
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201223114D0 (en) Novel peptide
HK1201752A1 (en) Alternaria peptides
EP2891663A4 (en) PEPTIDE DERIVED FROM PSF1
GB201221414D0 (en) Trans-locating peptide
GB201200623D0 (en) Peptide
GB201200624D0 (en) Peptide
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides
GB201207895D0 (en) Peptides
GB201200509D0 (en) Peptides
GB201210286D0 (en) Recombinant polypeptide
GB201205932D0 (en) Beri-beri glucagon based immunosuppresan tc